LIPIDS AS MODULATORS OF GENE EXPRESSION

脂质作为基因表达的调节剂

基本信息

  • 批准号:
    2884171
  • 负责人:
  • 金额:
    $ 1.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-06-01 至 2000-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from the applicant's abstract): It is known that specific lipids and their metabolites control the transcription of genes and mediate diverse aspects of intracellular signaling. Recent advances have defined the signaling molecule's transcription factors, auxiliary coactivators and corepressors and the mechanisms through which these factors act to regulate the expression of genes. These new insights may help to further our understanding of both normal physiological homeostatic control, i.e., cholesterol homeostasis mediated by feedback regulation through sterol-responsive element binding proteins (SREBPs) and the bases for certain pathophysiological states such as diabetes from insulin resistance and the role of peroxisomal proliferator activator receptor in this disease, also known as PPAR GAMMA. The opportunity to discover new therapeutics for the treatment of diseases caused by altered lipid metabolism, specifically hyperlipidemia, atherosclerosis, diabetes, obesity, and neurological disease has been realized by scientists working in research programs in academia and in industry. The function of this application is to provide support for the 1999 Kern Aspen Lipid Conference entitled "Lipids as Modulators of Gene Expression: Lipid Metabolism and Atherosclerosis." The goal of this is to present and discuss new findings in the area of transcriptional regulation of lipid metabolizing genes. The meeting is designed to allow for intensive didactic presentations and extensive interaction periods. Both directly following each presentation and during lunches and poster sessions the meeting will begin on Saturday afternoon and end mid-day Tuesday. A typical day's activities will include a four- to five-hour session with four speakers; each speaker will present for 30 minutes and then lead a discussion of 30 minutes. On Sunday a two-hour poster session is scheduled after lunch. Each poster session has 20 posters which will be presented by young investigators. One informal buffet dinner is held on Sunday evening to further allow for discussions between attendees. A brief summary of the meeting generally appears in the Journal of Lipid Research. The chairmen of the meeting are Roger Davis of San Diego State University and David Russell of the University of Texas SW Medical Center. Session I is transcriptional regulation of lipid metabolism; Session II is cellular signaling, gene expression and intracellular trafficking; Session III is the role of PPARgamma in lipid metabolism; and Session IV is gene expression in macrophages in the arterial wall. Session I will be moderated by Roger Davis, and speakers will be Joseph Goldstein, David Mangelsdorf, Bob Tjian, and H.S. Sul. The moderator is Session II will be David Russell, and speakers will be Phil Beachy, Thomas Sudhof, and Tom Innerarity. Session III will be moderated by Helen Hobbs; speakers will be Ron Evans, Chris Glass, Mike Milburn, and Helen Hobbs. Session IV will be moderated by Linda Curtiss and speakers will be Peter Edwards, Peter Libby, Steve Prescott, and Zena Werb. There will be an additional four oral sessions and two poster sessions.
描述(改编自申请人的摘要):我们知道,具体的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROGER A DAVIS其他文献

ROGER A DAVIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROGER A DAVIS', 18)}}的其他基金

MASS DETECTOR: METABOLISM OF LIPID
质量检测器:脂质代谢
  • 批准号:
    7166588
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
Agilent 6890 GC/5973 mass detector for Profiling
用于分析的 Agilent 6890 GC/5973 质量检测器
  • 批准号:
    6877331
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
MASS DETECTOR: GENE TRANSFER & ARTHEROSLEROSIS
质量检测器:基因转移
  • 批准号:
    7166586
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
MASS DETECTOR: IMMUNOLOGY
质量检测器:免疫学
  • 批准号:
    7166589
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
MASS DETECTOR: ZELLWEGER SYNDROME
质量探测器:齐韦格综合症
  • 批准号:
    7166587
  • 财政年份:
    2005
  • 资助金额:
    $ 1.5万
  • 项目类别:
CORE--EXPRESSION FACILITIES
核心——表达设施
  • 批准号:
    6109640
  • 财政年份:
    1998
  • 资助金额:
    $ 1.5万
  • 项目类别:
Intervention of Atherogenesis by Gene Transfer
通过基因转移干预动脉粥样硬化形成
  • 批准号:
    6662021
  • 财政年份:
    1997
  • 资助金额:
    $ 1.5万
  • 项目类别:
INTERVENTION IN ATHEROGENESIS BY 7ALPHA HYDROXYLASE
7α 羟化酶干预动脉粥样硬化
  • 批准号:
    6183918
  • 财政年份:
    1997
  • 资助金额:
    $ 1.5万
  • 项目类别:
CORE--EXPRESSION FACILITIES
核心——表达设施
  • 批准号:
    6241739
  • 财政年份:
    1997
  • 资助金额:
    $ 1.5万
  • 项目类别:
INTERVENTION IN ATHEROGENESIS BY 7ALPHA HYDROXYLASE
7α 羟化酶干预动脉粥样硬化
  • 批准号:
    2031188
  • 财政年份:
    1997
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似海外基金

EukaryoticHopanoids: Deciphering the regulatory network behind unusual lipids in eukaryotes
真核Hopanoids:破译真核生物异常脂质背后的调控网络
  • 批准号:
    EP/Y024702/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Fellowship
Conference: 26th International Symposium on Plant Lipids
会议:第26届国际植物脂质研讨会
  • 批准号:
    2416127
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Standard Grant
Glucagon-like peptide 1 and 2 double receptor knockout (GLPDRKO) mice have higher post-prandial lipids and glucose in a sex- and meal-dependent manner
胰高血糖素样肽 1 和 2 双受体敲除 (GLPDRKO) 小鼠具有较高的餐后血脂和血糖,且具有性别和膳食依赖性
  • 批准号:
    495444
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Breath biopsy technology targeting for volatile oxidized lipids
针对挥发性氧化脂质的呼吸活检技术
  • 批准号:
    23K06080
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development and evaluation of a method to assess nutritional quality of dietary lipids in food
食品中膳食脂质营养质量评估方法的开发和评价
  • 批准号:
    2890339
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Studentship
Integral Membrane Proteins and Lipids Ejected from the Membranes of Native Tissues
从天然组织膜中排出的完整膜蛋白和脂质
  • 批准号:
    EP/Y029259/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Research Grant
Development and evaluation of a method to assess the nutritional quality of dietary lipids in food
食品中膳食脂质营养质量评估方法的开发和评价
  • 批准号:
    BB/Y512382/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Training Grant
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
  • 批准号:
    10643344
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
  • 批准号:
    10722515
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Impact of inflammatory lipids on Yersinia pestis infection
炎性脂质对鼠疫耶尔森菌感染的影响
  • 批准号:
    10722648
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了